CD8A and neoplasm: Therefore, blocking their inhibitory signaling using anti-PD1/CTLA-4 antibodies could rejuvenate exhausted CD8+ T cells, enhance their cytotoxicity, promote tumor cell lysis, and restrict tumor metastasis [29].